Evidence map›Paper›PMID 40936922›Full record

ArticleFrontiers in immunology2025

Innate immune dysfunction and persistent activation in South African HIV elite controllers.

Asisipo Mohamed, Yenzekile Zungu, Sharon Shalekoff, Osman Ebrahim, Ziyaad Waja, Neil Martinson, Caroline T Tiemessen, Christina Thobakgale

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Asisipo MohamedSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Yenzekile ZunguSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sharon ShalekoffSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Osman EbrahimSchool of Therapeutic Sciences, Department of Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ziyaad WajaPerinatal HIV Research Unit, Chris Hani Baragwanath Academic Hospital, Soweto, University of the Witwatersrand, Johannesburg,, South Africa.
Neil MartinsonPerinatal HIV Research Unit, Chris Hani Baragwanath Academic Hospital, Soweto, University of the Witwatersrand, Johannesburg,, South Africa.
Caroline T TiemessenSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Christina ThobakgaleSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Elite controllers can spontaneously control HIV-1 infection without antiretroviral treatment but remain at risk of developing non-AIDS-related conditions. The adaptive immune system is key in mediating spontaneous viral control; however, the innate immune response remains understudied. We assessed the quality of the innate immune responses by evaluating the phenotype and function of antigen-presenting cells (APCs) in South African adults living with HIV (PWH). Methodology: A total of 73 black South Africans were included in this study. Of these, 55 were living with HIV and included 16 individuals with spontaneous viral control (PWH Results: Our findings show a reduced expression of CD86 on monocytes of PWH Conclusion: PWH

Indexed as

HIV-1HIV InfectionsHIV Long-Term SurvivorsImmunity, InnateAdultCytokinesDendritic CellsFemaleHumansMaleMiddle AgedMonocytesSouth AfricaCytokinesantigen-presenting cellsHIV-1HIV elite controllersmonocyte activationproinflammatory cytokines

Identifiers

PMID40936922
PMCPMC12420260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.